Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress (Q37703990)

22 August 2017

1 reference

title

Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress (English)

1 reference

22 August 2017

1 reference

Ibrahim Abdulwahid Arif

series ordinal

1

1 reference

22 August 2017

Haseeb Ahmad Khan

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Toxicology and Industrial Health

22 August 2017

published in

1 reference

22 August 2017

volume

26

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

121-128

1 reference

Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Production of reactive oxygen species by mitochondria: central role of complex III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP , or paraquat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Complex I is the major site of mitochondrial superoxide production by paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Nicotine protects rat brain mitochondria against experimental injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

MPP( )-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Pesticide/environmental exposures and Parkinson's disease in East Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Paraquat exposure as an etiological factor of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Paraquat neurotoxicity is mediated by a Bak-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Role of mitochondria in neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Complex I and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Generation of reactive oxygen species by the mitochondrial electron transport chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Parkinson's disease, pesticides, and glutathione transferase polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Complex I deficiency in Parkinson's disease frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

The inhibition site of MPP , the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Paraquat neurotoxicity is distinct from that of MPTP and rotenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Effects of paraquat on mitochondrial electron transport system and catecholamine contents in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0748233710362382

21 January 2018

Identifiers

DOI

10.1177/0748233710362382

1 reference

22 August 2017

1 reference